Topic filter : Pascal Soriot

Most trending topics in Business & Finance ( last 24 hours ):
Railway Airline KLM Bank Account Technology TSB Inflation Cost Of Living Brexit Branded Product Premier Foods Mr Kipling Recession Euro Investigation Tax Avoidance Recruitment British Gas High Street Sanction Treasury Tax Relief Mortgage Interest-only Fracking Profit Annual Profit Mike Ashley Sports Direct Economy Airbnb Rupert Murdoch Sky Compensation Channel 4 Stock Exchange State Pension Pension Life Expectancy Labour Jeremy Corbyn

Socially Most Trending News

.... The rest of us should deplore a grubby little arrangement. Come on, Pascal Soriot, don’t be shy. ... [Read full article on Guardian ]
Thursday 13th of July 2017 06:21:05 PM
Total Trend count
5
Most trending on :
3 2

Latest Finance News related to Pascal Soriot

Will Lloyds chief enjoy plain sailing or will he jump ship? | Nils Pratley image
.... In 2014, almost 40% of shareholders voted against the pay report. Now they’ve done so again, presumably objecting to last year’s £13m pay package for chief executive Pascal Soriot, which inevitably flowed in large part from the flowering of a long-term incentive scheme. ...
AstraZeneca shareholders revolt over chief executive's £13m pay image
Source : Guardian [Read Article] Thursday 27th of April 2017 06:13:55 PM
.... Support for the new pay policy was much stronger, with 96% of investors backing it. AstraZeneca’s chief executive, Pascal Soriot, received a total pay package of £13. ...
Sports Direct's French Connection flutter looks like a fashion faux pas | Nils Pratley image
....Aren’t our big pharmaceutical firms meant to be depressed about Brexit and the prospect of the European Medicines Agency (EMA), the pan-EU regulator, moving out of London?. Pascal Soriot, chief executive of AstraZeneca, didn’t exactly sound excited but he made a couple of interesting points about the EMA’s departure, which he views as inevitable. ...
AstraZeneca to move some UK jobs to Poland, Costa Rica and Malaysia image
Source : Guardian [Read Article] Sunday 4th of December 2016 01:26:06 PM
....1bn by the end of 2017, through a series of cost-cutting measures. At the time, the chief executive, Pascal Soriot, said most job cuts would affect the company’s non-British salesforce and the impact on the UK would be minimal. ...
Trump's $1tn pledge sounds impressive but beware the small print image
Source : Guardian [Read Article] Thursday 10th of November 2016 07:45:58 PM
.... Hillary Clinton, who had pledged to cap drug prices, will not be entering the White House but it’s hard to know what Trump’s changes imply. Pascal Soriot, chief executive of AstraZeneca, has the right idea. ...
AstraZeneca chief: US healthcare set for big changes under Trump image
Source : Guardian [Read Article] Thursday 10th of November 2016 02:22:21 PM
....AstraZeneca’s boss has warned of major healthcare changes in the US after Donald Trump’s surprise election victory. Pascal Soriot, chief executive of the UK drugmaker, said the Affordable Care Act, known as Obamacare, which has helped millions of Americans get health insurance, was likely to be scrapped or substantially altered once Trump takes office. ...
Top FTSE 100 bosses landed pay rises of nearly £100m in 2015 image
Source : Guardian [Read Article] Friday 10th of June 2016 12:52:16 PM
....The third largest rise was awarded to Sky’s Jeremy Darroch, who more than trebled his pay to £16. 9m, followed by Pascal Soriot of AstraZeneca, who more than doubled his package to just under £4. ...
City news: Restaurant Group, WPP, British Airways and AstraZeneca image
Source : Daily Express [Read Article] Saturday 30th of April 2016 12:01:00 AM
....Astra, which is working on treatments to replace lost revenue from blockbuster drugs losing patent protection, is focusing on areas including diabetes, respiratory conditions and oncology. Chief executive Pascal Soriot said: “We are also driving greater efficiency. ...
AstraZeneca focuses on cancer treatments as profits slide image
Source : Guardian [Read Article] Friday 29th of April 2016 09:00:18 AM
.... Its bestselling cholesterol pill Crestor faces generic competition in the US from next week. The chief executive, Pascal Soriot, highlighted double-digit sales growth in China, a shift towards specialty care and progress with new cancer treatments, which contributed $99m (£68m) of revenues in the first quarter. ...
AstraZeneca slips on talk of possible £7bn bid for US cancer specialist image
.... Shore Capital’s Dr Tara Raveendran said:. A bid for the company would fit with AstraZeneca’s recent strategic focus on oncology, with durvalumab, Lynparza and Tagrisso expected to collectively earn $12bn per annum in sales by 2023F a significant proportion of the $45bn target set by chief executive Pascal Soriot following the Pfizer-bid. ...
Share Hunter: AstraZeneca makes £82m from new cancer drug but rivals pile on the pressure image
.... Six regulatory approvals were received in the year and Astra anticipates six more regulatory submissions and about 10 major data readouts – the results from trials of drugs to see if they are successful. Longer-term, CEO Pascal Soriot is backing Astra’s drug pipeline to reignite growth. ...
City News: Marks and Spencers, South Western, Astra and Vodafone image
Source : Daily Express [Read Article] Thursday 4th of February 2016 07:58:00 PM
....The pharma giant is rebuilding its new medicines pipeline to replace blockbusters such as cholesterol treatment Crestor, which will shortly lose patent protection in America. Chief executive Pascal Soriot said: “Clearly 2016 will be a very challenging year due to the loss of exclusivity for Crestor in the US. ...
AstraZeneca warns of declining profits image
Source : Guardian [Read Article] Thursday 4th of February 2016 01:46:14 PM
....20, well below the £55 a share price offered by the US drugmaker Pfizer nearly two years ago when it tried to take over the group in a £70bn deal. Its chief executive, Pascal Soriot, said: “Clearly 2016 will be a very challenging year due to the loss of exclusivity for Crestor in the United States [in May]. ...
Crestor-owner warns of declining profits image
Source : BBC [Read Article] Thursday 4th of February 2016 07:37:49 AM
....4bn) last year, which was considerably more than any other AstraZeneca drug. "As we face the transitional period of patent expiry for Crestor in the US, we're confident that our strong execution on strategy, combined with the benefits of focused investments and new launches, keeps us on track to return to sustainable growth in line with our targets," said chief executive Pascal Soriot. ...
AstraZeneca's lung cancer pill wins speedy EU approval image
Source : Telegraph [Read Article] Wednesday 3rd of February 2016 12:01:50 PM
.... . Its chief executive, Pascal Soriot, has previously said the pharmaceuticals giant has "one of the most exciting pipelines in the industry". ...
Workers could hold key to unlocking executive pay gap image
Source : Guardian [Read Article] Friday 18th of December 2015 12:01:40 AM
.... If Acerta’s rival is merely highly likely to be approved, and if AstraZeneca genuinely thinks it will be “best in class”, then $4bn plus $3bn looks reasonable. Attractive odds, however, won’t spare chief executive Pascal Soriot’s blushes if his nag crashes at the final regulatory hurdle. ...
City news: AstraZeneca, Paddy Power & Betfair merger, Heathrow boss and Entertainment One  image
....Acalabrutinib, a potential multibillion-dollar-a-year seller, is one of a range of cancer drugs Acerta is developing. Astra chief Pascal Soriot said it “could transform treatment” for blood cancer patients. ...
FTSE jumps 1% after Fed rate rise while AstraZeneca buoyed by biotech deal image
Source : Guardian [Read Article] Thursday 17th of December 2015 09:56:17 AM
.... Earlier in the week, AstraZeneca had said it was looking at strategic options with Acerta, which is based in California and the Netherlands. The move gives AstraZeneca access to a new treatment for blood cancers, and chief executive Pascal Soriot said:. ...
AstraZeneca buys majority stake in blood cancer specialist Acerta for £2.68bn image
Source : Telegraph [Read Article] Thursday 17th of December 2015 09:20:37 AM
.... . Pascal Soriot, chief executive of AstraZeneca, said: “We are boosting a key area in our comprehensive oncology portfolio with a late-stage, potential best-in-class medicine that could transform treatment for patients across a range of blood cancers. ...
AstraZeneca splashes out in far east despite China's ailing economy image
Source : Guardian [Read Article] Wednesday 16th of December 2015 06:56:06 PM
.... When the board fended off a £69. 4bn takeover bid from New York rival Pfizer in May last year, chief executive Pascal Soriot pledged to raise annual sales by 75% to $45bn by 2023. ...
AstraZeneca chases Acerta to secure next cancer drug winner image
Source : Guardian [Read Article] Monday 14th of December 2015 09:45:37 AM
.... Last week, it reported positive results in leukaemia. The decision to chase after Acerta reflects a determination by the AstraZeneca chief executive, Pascal Soriot, to use deals to boost his company’s pipeline as sales of older blockbusters, including cholesterol fighter Crestor, lose patent protection. ...
AstraZeneca lung cancer drug given green light in US image
Source : Guardian [Read Article] Friday 13th of November 2015 06:08:58 PM
....Lung cancer is the leading cause of cancer death among men and women, accounting for a third of cancer deaths, more than breast, prostate and colorectal cancers combined. The treatment, developed in Cheshire, is one of several highlighted by AstraZeneca chief executive Pascal Soriot in his defence against a £69bn takeover approach from American rival Pfizer, the maker of Viagra, last year. ...
FTSE 100 giant AstraZeneca set to buy ZS Pharma image
Source : Daily Express [Read Article] Friday 6th of November 2015 07:12:00 PM
....However, AstraZeneca sought to dampen fears over the impact of the loss of patent protections as it flagged higher annual sales and profits, helped by strong sales of new treatments such as heart drug Brilinta. Chief executive Pascal Soriot said the ZS acquisition was a “strong fit” with its pipeline and portfolio in cardiovascular and metabolic disease, one of its three main therapy areas. ...
AstraZeneca to buy ZS Pharma for $2.7bn image
Source : Telegraph [Read Article] Friday 6th of November 2015 10:01:33 AM
.... . Pascal Soriot, chief executive of AstraZeneca, said: "Hyperkalaemia can be a life-threatening condition for patients with chronic kidney disease and chronic heart failure, however the risk is underappreciated and prevalence is increasing. ...
AstraZeneca agrees $2.7bn deal for US biotech firm ZS Pharma image
Source : Guardian [Read Article] Friday 6th of November 2015 09:45:58 AM
.... The US company has about 200 employees across three sites in California, Texas and Colorado. Pascal Soriot, AstraZeneca’s chief executive, said: “Hyperkalemia can be a life-threatening condition for patients with chronic kidney disease and chronic heart failure. ...
City news: Astrazeneca, car sales, Electra, Superdry image
Source : Daily Express [Read Article] Thursday 5th of November 2015 07:40:00 PM
....It was helped by strong sales of newer products such as heart drug Brilinta. Chief Pascal Soriot said: “2016 will be pivotal as we face the impact of loss of exclusivity to [cholesterol medicine] Crestor in the US. ...
FTSE falls ahead of Bank rate decision but AstraZeneca and RSA rise image
Source : Guardian [Read Article] Thursday 5th of November 2015 09:57:09 AM
.... The company, which saw off a $118bn takeover bid from Pfizer last year, said third quarter revenue fell 10% with earnings per share down 2%, but these figures were in line with expectations. Key products such as heartburn drug Nexium and cholesterol treatment Crestor face growing generic competition, and chief executive Pascal Soriot said:. ...
AstraZeneca raises guidance as profits jump image
Source : Telegraph [Read Article] Thursday 5th of November 2015 08:58:35 AM
.... . “This will be a pivotal year in our strategic journey as we face the impact of loss of exclusivity to Crestor in the US,” said chief executive Pascal Soriot. ...
Revealed: how AstraZeneca avoids paying UK corporation tax image
Source : Guardian [Read Article] Sunday 4th of October 2015 10:10:19 PM
....But British diplomats, while supportive of many OECD reforms, have battled behind the scenes to to protect prized tax policies that helped make Britain a favourable environment for the location of international business. Pascal Soriot, AstraZeneca’s chief executive, was among more than 100 business leaders who signed an open letter in support of Conservative party tax policies during the general election campaign earlier this year. ...
AstraZeneca heart disease drug gets wider FDA approval image
Source : Guardian [Read Article] Friday 4th of September 2015 10:41:36 AM
....Brilinta is one of the big earners AstraZeneca is counting on to offset falling sales from older bestsellers as they come off patent, such as Nexium and Crestor. Brilinta has had a bumpy ride since being launched in 2011 but the AstraZeneca boss, Pascal Soriot, has talked it up as a diamond in the rough. ...
AstraZeneca reboots psoriasis drug in development deal with Valeant image
Source : Telegraph [Read Article] Tuesday 1st of September 2015 07:34:02 AM
.... . "Our agreement will help to bring brodalumab to patients with psoriasis who need new treatment options through Valeant's expert focus on dermatology,” said Pascal Soriot, chief executive officer of AstraZeneca. ...
AstraZeneca names Sean Bohen as chief medical officer image
Source : Telegraph [Read Article] Monday 24th of August 2015 07:39:32 AM
.... . “I’m delighted to welcome Sean to AstraZeneca at a very exciting time for our company,” said Pascal Soriot, chief executive. ...
Shire pharmaceutical makes $30bn move for Baxalta image
Source : Guardian [Read Article] Tuesday 4th of August 2015 01:21:14 PM
.... Scientists, trade unions and politicians on both sides of the Atlantic had lined up to criticise a deal they said was motivated by tax avoidance and cuts to research jobs. AstraZeneca thinks a repeat offer is unlikely: boss Pascal Soriot has said the tightening of US tax rules means US firms are less likely to attempt to takeover their foreign rivals to reduce their tax bills. ...
Astrazeneca's blood thinning drug helps beat City estimates image
Source : Telegraph [Read Article] Thursday 30th of July 2015 08:33:36 AM
.... . The uplift in revenue guidance comes as AstraZeneca’s chief executive, Pascal Soriot, attempts to turn the business round by accelerating investment in research and development, particularly in cancer treatment, to bolster the UK drugmaker’s pipeline. ...
AstraZeneca chief medical officer departing to join small biotech firm image
Source : Guardian [Read Article] Wednesday 10th of June 2015 09:15:03 PM
....He is joining a small, privately owned biotech company whose identity has not been revealed, in a move that surprised industry watchers. AstraZeneca’s chief executive, Pascal Soriot, will take over the job of late-stage drug development on an interim basis, while Elisabeth Björk, an associate professor of medicine at Uppsala university, who leads cardiovascular and metabolic drug development at AstraZeneca, becomes acting chief medical officer. ...
Market Report: Claims AstraZeneca has made $200-a-share offer for Receptos image
Source : Independent [Read Article] Wednesday 10th of June 2015 04:45:00 AM
.... Israel’s Teva Pharmaceuticals, which is embroiled in the hostile takeover of Mylan Laboratories, and America’s Gilead Sciences are also vying for Receptos’s affections. AstraZeneca, under the guidance of French chief executive Pascal Soriot, has been beefing up its drug pipeline in an effort to offset expiring patents. ...
Questor share tip:Cancer breakthrough proves AstraZeneca was right to spurn Pfizer offer image
.... . Pascal Soriot, AstraZeneca’s chief executive, believes the tipping point of new drug developments replacing the falling sales of old treatments is getting closer. ...
AstraZeneca's revenue ambitions hit by psoriasis drug setback image
Source : Telegraph [Read Article] Tuesday 26th of May 2015 04:40:57 PM
.... . AstraZeneca’s chief executive, Pascal Soriot, hung his ambitious target on the group’s reinvigorated pipeline of drugs which includes medicines for cancer, lung problems and diabetes. ...
....Pfizer could have struck back with another bid, but AstraZeneca has made a decent fist of moving on. Sure, its sales targets have been set out so far in the distance that it will fall to chief executive Pascal Soriot’s successor to disown them if the company doesn’t look like it is going to get there. ...
If its Astra bid was crazy, is Pfizer plotting something even more bonkers?  image
.... . This totally played into the hands of AstraZeneca and its French chief executive, Pascal Soriot, who was allowed to get away with silly, emotive comments about how a takeover would be a huge distraction and cost lives. ...
Investors in pay revolt at AstraZeneca image
Source : Independent [Read Article] Friday 24th of April 2015 10:43:16 PM
....Ashley Hamilton Claxton, the corporate governance manager at Royal London Asset Management, said: “Aspects of AstraZeneca’s long-term incentive plan are largely opaque. “We are supportive of management but expect better transparency around the performance conditions considering the high level of pay [chief executive] Pascal Soriot may receive. ...
AstraZeneca announces new cancer deals with first-quarter results image
Source : Guardian [Read Article] Friday 24th of April 2015 08:38:05 AM
.... AstraZeneca is trying to keep up with rivals such as Bristol-Myers Squibb, Merck and Roche, and is now running 72 clinical cancer trials, including 31 in immuno-oncology. AstraZeneca’s chief executive Pascal Soriot said: “It’s a very competitive field. ...
AstraZeneca profits fall on strong dollar image
Source : Telegraph [Read Article] Friday 24th of April 2015 06:35:00 AM
.... . Chief executive Pascal Soriot told investors earlier this year that sales will begin to climb consistently from 2017, after which time it expects new drugs to have gained enough momentum to offset declining revenues of old blockbusters that have lost patent protection. ...
AstraZeneca reports strong progress with cancer drugs ahead of results image
.... Successes are desperately needed as AstraZeneca is rebuilding its pipeline of new drugs following a series of patent losses on bestsellers such as stomach pill Nexium and cholesterol fighter Crestor. Chief executive Pascal Soriot pledged to lift company sales to $45bn by 2023, from $26bn last year – a target seen by many analysts as ambitious. ...
Scrapping non-dom tax status would hit bank chiefs image
Source : Telegraph [Read Article] Sunday 12th of April 2015 04:39:26 PM
.... . Other FTSE 100 non-dom bosses who do not pay tax on their overseas earnings include Pascal Soriot at Astrazeneca, and Mark Wilson, chief executive of Aviva. ...
Three business leaders distance themselves from pro-Tory letter image
Source : Guardian [Read Article] Thursday 2nd of April 2015 04:30:18 PM
.... But I am also very critical of Tory policies on education, immigration and defence,” he said. Pascal Soriot, the chief executive of AstraZeneca, appeared to endorse the letter on Thursday morning. ...
Failed cancer drug could be used to treat Alzheimer's image
Source : Telegraph [Read Article] Wednesday 1st of April 2015 05:42:22 PM
.... . It still has a research unit dedicated to neurological problems, but chief executive Pascal Soriot has indicated that any promising treatments to emerge from this group are more likely to be developed with partners rather than taken forward solely by AstraZeneca. ...
Thank you for flying AstraZeneca Airways image
Source : Telegraph [Read Article] Saturday 14th of February 2015 07:00:41 PM
.... . Pascal Soriot, chief executive, told the Telegraph that the air link was conceived as a way to make Cambridge and Gothenburg behave as if they were one giant research hub. ...
AstraZeneca unveils $600m Actavis deal as full-year results disappoint image
Source : Telegraph [Read Article] Thursday 5th of February 2015 07:38:39 AM
. AstraZeneca boss Pascal Soriot appealed for investor patience after the company posted lower-than-expected revenues and earnings for the final quarter of the year, but bolstered its portfolio with a new deal. ...
AstraZeneca's boost from heart attack drug Brilinta image
Source : Daily Express [Read Article] Thursday 15th of January 2015 09:45:00 AM
....Results from the 21,000–patient study showed that Brilinta, which the company hopes could become a blockbuster treatment with £2billion-plus annual sales, benefits patients more than a year after they have had an attack when taken alongside a low dose of aspirin. AstraZeneca's chief executive Pascal Soriot identified the treatment as an important part of its targeted annual revenue of £30billion by 2023, which was set last year as it fended off a takeover bid by US giant Pfizer. ...
Exclusive: UK firms vie for share of £170bn in Algeria deals image
Source : Independent [Read Article] Monday 8th of December 2014 12:09:35 AM
....Philip Hammond, the Foreign Secretary, is opening the conference with Mr Sellal and Lord Risby, the UK’s trade envoy for Algeria. Pascal Soriot, AstraZeneca’s chief executive, Ayman Asfari, Petrofac’s chief executive, Roger King, the boss of the heathcare service specialist International Hospitals Group, and Sir Chris Evans of Excalibur, a biomedical science investment boutique, will attend. ...
Pascal Soriot: inversion deals are not dead yet image
Source : Telegraph [Read Article] Sunday 30th of November 2014 10:35:29 AM
.... . Pascal Soriot, who fought off a £69bn takeover attempt by American rival Pfizer in May, said while it has become more “complicated” to structure inversion deals, that they were still possible. ...
AstraZeneca boss claims 'inversion deals aren't dead' image
Source : Telegraph [Read Article] Saturday 29th of November 2014 07:05:43 PM
.... . Pascal Soriot, who fought off a £69bn takeover attempt by American rival Pfizer in May, said that while it has become more “complicated” to structure inversion deals, they were still possible. ...
Neil Woodford: there's a 50/50 chance Pfizer will come back for AstraZeneca image
Source : Telegraph [Read Article] Tuesday 18th of November 2014 03:55:52 PM
.... . Pascal Soriot, chief executive, said cancer would become the company's sixth "growth platform". ...
Healthy US sales boost AstraZeneca image
Source : Daily Express [Read Article] Friday 7th of November 2014 11:38:00 AM
....It was helped by the delayed US launch of generic copies of Nexium, which kept cash flowing from the heartburn and ulcer treatment, while the company also pointed to a healthy performance in growth areas such as treatments for diabetes. Chief executive Pascal Soriot said: "We have chosen to invest in our rapidly developing pipeline that will continue to create value for AstraZeneca in 2015 and beyond. ...
City Diary: Mystery over Viking River Cruises' Chinese tipping charges image
Source : Telegraph [Read Article] Friday 7th of November 2014 05:00:37 AM
.... ------------------------- . Pascal Soriot, the boss of drug-maker AstraZeneca, had an unusual request for the pharmaceutical scribblers on the conference call for yesterday’s third-quarter results. ...
AstraZeneca raises sales outlook as rival drugs are hit by delays image
Source : Independent [Read Article] Thursday 6th of November 2014 12:13:49 PM
....Then, in May, Viagra-maker Pfizer began its prolonged and ultimately unsuccessful takeover attempt. In fighting off that bid, AstraZeneca chief executive Pascal Soriot promised a 75 per cent increase in revenues to  $45 billion by 2023 — but there’s a long way to go: City analysts forecast this year’s figure will hit just $25. ...
AstraZeneca brightens outlook for second time in three months image
Source : Telegraph [Read Article] Thursday 6th of November 2014 07:50:51 AM
.... . Pascal Soriot, chief executive, cheered the "rapid transformation" of the company, which just a year ago was limping along with falling sales due to the loss of exclusivity on some of its top products. ...
AstraZeneca star heart drug cleared from concerns over major clinical trial image
.... . Pascal Soriot, AstraZeneca chief executive, welcomed the DoJ's decision against pursuing further action into the trial, which provided key evidence that Brilinta, taken with aspirin, reduced the risk of blood clots following a heart attack. ...
Clash of the egos: When boardroom bust-ups derail deals image
Source : Telegraph [Read Article] Saturday 9th of August 2014 02:37:12 PM
.... For example, Pfizer’s approach of AstraZeneca and its gung-ho attitude to what would have been the biggest ever foreign takeover of a UK company was swiftly dampened when the board was hauled over the hot coals by two committees of MPs. Sources have also admitted there was a serious misjudgement of the emotional arguments that Pascal Soriot would employ with the aim of defending British jobs. ...
'Mergers aren't always marriages made in heaven' image
Source : Telegraph [Read Article] Saturday 2nd of August 2014 07:17:32 PM
.... . Despite agreeing to increase its offer price significantly during the prolonged bid process, it was Pfizer chairman and chief executive Ian Read’s mis-reading of what motivated both Leif Johansson and Pascal Soriot, his Astra opposite numbers, that arguably led the bid to fail. ...
Hedge funds bet against a quick AstraZeneca takeover image
Source : Telegraph [Read Article] Saturday 2nd of August 2014 06:53:28 PM
.... The UK drug maker unveiled buoyant results last week which led it to raise its full-year outlook. Chief executive Pascal Soriot plans to double sales by 2023. ...
Astrazeneca predict healthy sales image
Source : Daily Express [Read Article] Friday 1st of August 2014 12:01:00 AM
.... Its shares fell 13p to 4344½p. AstraZeneca, led by chief executive Pascal Soriot, said annual revenues would now come in line with last year’s $25. ...
Astrazeneca restocks with Almirall asthma-drug deal image
Source : Daily Express [Read Article] Thursday 31st of July 2014 12:01:00 AM
.... . Its chief executive Pascal Soriot said: “Our agreement with Almirall brings strategic and long-term value to AstraZeneca’s strong respiratory franchise, one of our key growth platforms. ...
MORNING MEETING: ITV figures to turn on investors image
Source : Daily Express [Read Article] Thursday 31st of July 2014 12:01:00 AM
....America's P?zer said this  week it remains on the  acquisition trail despite its  £69billion pursuit of AstraZeneca  ending in failure in May. Whether it returns for another tilt  remains to be seen but Astra’s chief  executive Pascal Soriot is keen to  build up the FTSE 100 company’s  takeover-immune system through  research breakthroughs and bolt-on  deals, the latest of which will see it  pay up to £1. ...
Source : Independent [Read Article] Wednesday 30th of July 2014 11:41:18 PM
....The pharmaceutical giant rebuffed Pfizer’s £55 a share takeover offer two months ago, setting out a strategy for going it alone that many saw as over ambitious. Yesterday boss Pascal Soriot shrugged off doubts, strengthening the company’s pipeline with the $2. ...
AstraZeneca boosts its lung drugs power with $2bn Almirall deal image
Source : Guardian [Read Article] Wednesday 30th of July 2014 12:50:51 PM
.... AstraZeneca is trailing behind rivals such as GlaxoSmithKline and Novartis in the race to develop the new class of drugs. AstraZeneca is due to report its second-quarter results on Thursday, when its chief executive, Pascal Soriot, will set out its strategy as an independent company. ...
AstraZeneca to unveil Cambridge plans image
Source : Telegraph [Read Article] Saturday 12th of July 2014 10:00:36 PM
.... . Pascal Soriot, chief executive, devised the move in an effort to tap into the town’s academic talent and expertise in biomedical science, particularly in the area of cancer research. ...
AbbVie battle for Shire: why this time it's different image
Source : Telegraph [Read Article] Saturday 5th of July 2014 07:00:15 PM
MORNING MEETING: Shareholders to vote today on £200million Sports Directs bonus scheme image
....The gap between honour and dishonour is a small one and bridging it is a huge task. AstraZeneca’s chief executive Pascal Soriot has put his money where his mouth is after rejecting a £69billion takeover approach by US drugs rival Pfizer. ...
....Speculators hoping AstraZeneca might still be in play after Pfizer's abortive bid might want to reconsider. The pharmaceutical giant revealed that boss Pascal Soriot bought £2m worth of shares in Astra on Monday, implying no takeover talks are happening. ...

Page rendered in 1.8804 seconds.